Osteoarthritis: pathogenic signaling pathways and therapeutic targets
Osteoarthritis (OA) is a chronic degenerative joint disorder that leads to disability and affects
more than 500 million population worldwide. OA was believed to be caused by the wearing …
more than 500 million population worldwide. OA was believed to be caused by the wearing …
Emerging pharmaceutical therapies for osteoarthritis
A Latourte, M Kloppenburg, P Richette - Nature Reviews Rheumatology, 2020 - nature.com
The prevalence of osteoarthritis (OA) and the burden associated with the disease are
steadily increasing worldwide, representing a major public health challenge for the coming …
steadily increasing worldwide, representing a major public health challenge for the coming …
Current research on pharmacologic and regenerative therapies for osteoarthritis
Osteoarthritis (OA) is a degenerative joint disorder commonly encountered in clinical
practice, and is the leading cause of disability in elderly people. Due to the poor self-healing …
practice, and is the leading cause of disability in elderly people. Due to the poor self-healing …
Exosomes derived from human urine–derived stem cells overexpressing miR-140-5p alleviate knee osteoarthritis through downregulation of VEGFA in a rat model
Y Liu, Y Zeng, HB Si, L Tang… - The American journal …, 2022 - journals.sagepub.com
Background: Knee osteoarthritis (KOA) is one of the most common chronic musculoskeletal
disorders worldwide, for which exosomes derived from stem cells may provide an effective …
disorders worldwide, for which exosomes derived from stem cells may provide an effective …
Regulatory effects and interactions of the Wnt and OPG-RANKL-RANK signaling at the bone-cartilage interface in osteoarthritis
Cartilage and the bordering subchondral bone form a functionally active regulatory interface
with a prominent role in osteoarthritis pathways. The Wnt and the OPG-RANKL-RANK …
with a prominent role in osteoarthritis pathways. The Wnt and the OPG-RANKL-RANK …
Systemic inhibition of IL-6/Stat3 signalling protects against experimental osteoarthritis
A Latourte, C Cherifi, J Maillet, HK Ea… - Annals of the …, 2017 - ard.bmj.com
Objective To investigate the impact of systemic inhibition of interleukin 6 (IL-6) or signal
transducer and activator of transcription (Stat3) in an experimental model of osteoarthritis …
transducer and activator of transcription (Stat3) in an experimental model of osteoarthritis …
Wnt signaling: a promising target for osteoarthritis therapy
Y Wang, X Fan, L Xing, F Tian - Cell Communication and Signaling, 2019 - Springer
Osteoarthritis (OA) is the most common joint disease worldwide and a leading cause of
disability. Characterized by degradation of articular cartilage, synovial inflammation, and …
disability. Characterized by degradation of articular cartilage, synovial inflammation, and …
Targeting VEGF and its receptors for the treatment of osteoarthritis and associated pain
JL Hamilton, M Nagao, BR Levine… - Journal of Bone and …, 2016 - academic.oup.com
Increased vascular endothelial growth factor (VEGF) levels are associated with osteoarthritis
(OA) progression. Indeed, VEGF appears to be involved in OA‐specific pathologies …
(OA) progression. Indeed, VEGF appears to be involved in OA‐specific pathologies …
[HTML][HTML] Wnt signaling in cartilage development and diseases: lessons from animal studies
Y Usami, AT Gunawardena, M Iwamoto… - Laboratory …, 2016 - Elsevier
Cartilage not only plays essential roles in skeletal development and growth during pre-and
postnatal stages but also serves to provide smooth movement of skeletons throughout life …
postnatal stages but also serves to provide smooth movement of skeletons throughout life …
Subchondral bone remodeling: a therapeutic target for osteoarthritis
There is emerging awareness that subchondral bone remodeling plays an important role in
the development of osteoarthritis (OA). This review presents recent investigations on the …
the development of osteoarthritis (OA). This review presents recent investigations on the …